Lawrence Livermore National Laboratory (LLNL) researchers have 3D printed live cells that convert glucose to ethanol and carbon dioxide gas (CO2), a substance that resembles beer, demonstrating a technology that can lead to high biocatalytic efficiency.
Bioprinting living mammalian cells into complex 3D scaffolds has been widely studied and demonstrated for applications ranging from tissue regeneration to drug discovery to clinical implementation. In addition to mammalian cells, there is a growing interest in printing functional microbes as biocatalysts.
Microbes are extensively used in industry to convert carbon sources into valuable end-product chemicals that have applications in the food industry, biofuel production, waste treatment and bioremediation. Using live microbes instead of inorganic catalysts has advantages of mild reaction conditions, self-regeneration, low cost and catalytic speci?city.
The new research, which appears as an ACS Editors’ Choice article in the journal Nano Letters, shows that the additive manufacturing of live whole-cells can assist in research in microbial behaviors, communication, interaction with the microenvironment and for new bioreactors with high volumetric productivity.
In a case study, the team printed freeze-dried live biocatalytic yeast cells (Saccharomyces cerevisiae) into porous 3D structures. The unique engineered geometries allowed the cells to convert glucose to ethanol and CO2 very efficiently and similar to how yeast on its own can be used to make beer. Enabled by this new bio-ink material, the printed structures are self-supporting, with high resolution, tunable cell densities, large scale, high catalytic activity and long-term viability. More importantly, if genetically modified yeast cells are used, high-valuable pharmaceuticals, chemicals, food and biofuels can be produced as well.
“Compared to bulk film counterparts, printed lattices with thin filament and macro-pores allowed us to achieve rapid mass-transfer leading to several-fold increase in ethanol production,” said LLNL materials scientist Fang Qian, the lead and corresponding author on the paper. “Our ink system can be applied to a variety of other catalytic microbes to address broad application needs. The bioprinted 3D geometries developed in this work could serve as a versatile platform for process intensi?cation of an array of bioconversion processes using diverse microbial biocatalysts for production of high-value products or bioremediation applications.”
Other Livermore researchers include Cheng Zhu, Jennifer Knipe, Samantha Ruelas, Joshua Stolaroff, Joshua DeOtte, Eric Duoss, Christopher Spadaccini and Sarah Baker. This work was conducted in collaboration with National Renewable Energy Laboratory.
“There are several benefits to immobilizing biocatalysts, including allowing continuous conversion processes and simplifying product purification,” said chemist Baker, the other corresponding author on the paper. “This technology gives control over cell density, placement and structure in a living material. The ability to tune these properties can be used to improve production rates and yields. Furthermore, materials containing such high cell densities may take on new, unexplored beneficial properties because the cells comprise a large fraction of the materials.”
“This is the first demonstration for 3D printing immobilized live cells to create chemical reactors,” said engineer Duoss, a co-author on the paper. “This approach promises to make ethanol production faster, cheaper, cleaner and more efficient. Now we are extending the concept by exploring other reactions, including combining printed microbes with more traditional chemical reactors to create ‘hybrid’ or ‘tandem’ systems that unlock new possibilities.”
Learn more: 3D-printed live cells convert glucose to ethanol, carbon dioxide to enhance catalytic efficiency
The Latest on: Biocatalysts
[google_news title=”” keyword=”biocatalysts” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biocatalysts
- Synthetic Antibiotics Could Improve Treatment of “Superbugs”on May 7, 2024 at 6:21 am
Technology Networks spoke to Dr. Ishwar Singh to learn more about the challenges of drug-resistant infections, the discovery of teixobactin and the benefits of synthetic antibodies.
- Gevo: Hold Rating Justified by Mixed Financial Performance and Promising Strategic Initiativeson May 3, 2024 at 1:15 pm
In a report released today, Dushyant Ailani from Jefferies maintained a Hold rating on Gevo (GEVO – Research Report), with a price target ...
- Gevo Inc.: Strong Buy Recommendation Amidst Progress on Net Zero 1 Plant and Strategic Financial Managementon May 3, 2024 at 3:17 am
Analyst Amit Dayal from H.C. Wainwright maintained a Buy rating on Gevo (GEVO – Research Report) and keeping the price target at $14.00.
- Global Starter Cultures Market Envisioned to Achieve US$ 2,154.3 Million by 2033, Fueled by 6.1% CAGRon April 26, 2024 at 12:42 am
The worldwide sales of starter cultures, which were previously estimated to be worth around US$ 1,123.1 million in 2022, are now expected to boost up. Currently, in the year 2023, the global starter ...
- Making sustainable biotechnology a reality: Joined forces aim to improve biocatalystson April 25, 2024 at 7:56 am
Everything biobased: plastic, medicine, and fuel. It seems like a futuristic utopia. But for how long? A collaboration of researchers now proposes an idea to accelerate the development process. By ...
- Light-driven enzyme engineered and repurposed to catalyse unnatural reactionon April 23, 2024 at 1:30 am
A natural photoenzyme found in algae has been artificially evolved to perform an unnatural and entirely new function for the first time. The work, which converted fatty acid decarboxylase (FAP) into ...
- LNZA LanzaTech Global, Inc.on March 5, 2024 at 3:25 am
It is also developing biocatalysts and processes to produce a suite of additional products utilizing novel biocatalysts, including acetone and isopropanol (IPA) and industrial solvents used in ...
- Powering nitrogenases: Researchers find new targets for improving biocatalystson February 26, 2024 at 8:12 am
With the two ferredoxins, the researchers have now identified clear targets to influence the electron flow and thus the performance of nitrogenases as biocatalysts. "Our results are an important ...
- Gevo, Inc.on November 14, 2023 at 8:01 pm
The Gevo segment focuses on the research and development activities related to the future production of isobutanol, including the development of the firm's proprietary biocatalysts, the production ...
- Maohong Fanon November 12, 2023 at 2:00 pm
They are also interested in the application of biocatalysts for biomass conversion to chemicals and fuels. In many cases they prepare and characterize nanoscale catalysts for these purposes.
via Bing News